In today’s Pharma Pulse, industry leaders warn of serialization security issues and pharma companies brace for the 2033 NDC ...
Regulatory regimes such as the EU FMD and U.S. DSCSA drive serialization to strengthen visibility and oversight, but these ...
Regulatory pressure from GxP, 21 CFR Part 11, and AI/ML guidance elevates requirements for audit trails, data lineage, ...
Pharmaceutical & Cosmetics Anti-Counterfeit Packaging Market In-Depth Insights, Business Opportunities And Top Companies Analysis Forecast By 2030. The Pharma & Cosmetic Anti-Counterfeit Packaging ...
GS1 Healthcare US is driving the adoption and implementation of GS1 standards to improve patient safety and supply chain efficiency. Members from across the pharmaceutical supply chain are building an ...
Authentication solutions emerge as pharma industry’s strongest shield against counterfeits at TAF Connect 2026: Shardul Nautiyal, Mumbai Friday, March 20, 2026, 08:00 Hrs [IST] ...
U.S. prescription drugs market project to grow from $634 billion market to $883 billion by 2030 according to Grandview Research [1] Global blockchain in healthcare market is projected to grow from $11 ...
M Second Phase of CDMO Investment Builds on 2025 $6M Expansion, Funding Facility Upgrades and Increased Capacity for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results